Edition:
United States

Magforce AG (MF6G.F)

MF6G.F on Frankfurt Stock Exchange

4.90EUR
3:57am EST
Change (% chg)

€-0.10 (-1.98%)
Prev Close
€5.00
Open
€5.05
Day's High
€5.05
Day's Low
€4.90
Volume
2,004
Avg. Vol
5,925
52-wk High
€5.90
52-wk Low
€3.82

Summary

Name Age Since Current Position

Norbert Neef

49 2011 Chairman of the Supervisory Board

Ben Lipps

76 2013 Chairman of the Management Board, Chief Executive Officer

Stephan Jakober

2013 Deputy Chairman of the Supervisory Board

Christian Von Volkmann

45 2012 Member of the Management Board, Chief Financial Officer

Barbara von Frankenberg

2016 Vice President Communications & Investor Relations

Hoda Tawfik

61 2012 Member of the Management Board, Chief Medical Officer

Wiebke Roesler

2014 Member of the Supervisory Board

Biographies

Name Description

Norbert Neef

Mr. Norbert Neef is Chairman of the Supervisory Board of MagForce AG since October 25, 2011. He is a founder and partner of Neef Legal Attornies, specializing in legal services for private equity, venture capital, and mergers & acquisitions. Mr. Neef began his career at international law firms. Mr. Neef serves on the advisory boards of several private companies and was most recently Chairman of the Supervisory Board of Mood and Motion AG. He also taught corporate law at Cologne University of Applied Sciences for ten years and has recently continued his teaching activities at the Fresenius University of Applied Sciences.

Ben Lipps

Dr. Ben J. Lipps is Chairman of the Management Board and Chief Executive Officer at Magforce AG since September 1, 2013. He became Chairman and Chief Executive Officer of the Management Board of Fresenius Medical Care in May 1999. In December 2012 he stepped down as Chairman of the Management Board and CEO. He was also Chief Executive Officer of Fresenius Medical Care North America until February 2004. He was President, Chief Executive Officer, Chief Operating Officer and a director of Fresenius USA from October 1989 through February 2004, and served in various capacities with Fresenius USA’s predecessor from 1985 through 1989. Before joining the Fresenius Group in 1985, Dr. Lipps held several research management positions in various companies, among them with DOW Chemical. He earned his master’s and doctoral degrees at the Massachusetts Institute of Technology in chemical engineering.

Stephan Jakober

Mr. Stephan Jakober is Deputy Chairman of the Supervisory Board at MagForce AG since October 1, 2013. He is an independent consultant of CIB Beratung AG, based in Zurich and is engaged in the areas of private equity, corporate finance, interim management and mergers & acquisitions. Previously Mr. Jakober took responsibility as Investment Director in Investments in mid-sized companies for several European private equity funds and was temporarily Chief Financial Officer at Film House Germany AG.

Christian Von Volkmann

Mr. Christian Von Volkmann is Member of the Management Board and Chief Financial Officer at MagForce AG since October 1, 2012. Prior to that, he served as Acting Chief Financial Officer of the Company from May 3, 2012. He has more than fourteen years of international experience in corporate finance/capital market transactions, group structuring and Mergers & Acquisitions. At Jerini AG (Berlin, Germany), which he joined in 2004, he served as Director of Finance. He also founded and headed Berlin-based CMaP Financial Consulting. Prior to his position at Jerini, Mr. von Volkmann worked at the auditing company Ernst & Young for six years. He holds a diploma of the Julius-Maximilians-Universitaet Wuerzburg, where he studied business administration with a focus on taxation, audit and consultancy as well as bank administration and Corporate Finance. He is also a licensed Certified Public Accountant in the United States.

Barbara von Frankenberg

Ms. Barbara von Frankenberg is Vice President Communications & Investor Relations of MagForce AG since March 16, 2016. Prior to joining MagForce, she spent 16 years as Investor Relations Manager, holding senior roles with publicly listed high-tech companies.

Hoda Tawfik

Prof. Dr. Hoda Tawfik has been Member of the Management Board and Chief Medical Officer of MagForce AG since October 1, 2012. Prior to that, she served as Vice President Clinical Development and Medical Affairs at the Company since May 2011. She is responsible for clinical development, production and development of particles, IP and customer service of the Company. Before joining the Company, she worked at Medigene AG, where she was head of global Clinical Operations and Medical Affairs for nine years. Prior to that, she managed the clinical programs at Medicore International, a contract research organization (CRO ). She has experience in managing research and development programs and an international network in the scientific community. She studied pharmacy at Cairo University, before taking a doctorate in pharmacology and toxicology at the Heinrich-Heine-Universitaet Dusseldorf. She also worked as a professor of pharmacology at Cairo University.

Wiebke Roesler

Dr. Wiebke Roesler is Member of the Supervisory Board of MagForce AG since August 19, 2014. She worked as specialist at Medizinische Hochschule Hannover, Center for Internal Medicine, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation. She has many years of experience as an internist specializing in hematology and oncology. She participated as sub investigator in clinical studies concerning Hodgkin-Lymphoma, Non-Hodgkin-Lymphoma, acute and chronic leukemia.